← All companies
OnPoint Vision, Inc.
Developing intraocular lenses to correct residual refractive error after cataract surgery and treat age-related retinal pathologies
healthcare AI/medtech ophthalmology
StageSeries B
Raised$11 million
Founded2019
Employees7
LocationAliso Viejo, CA
Business modelB2B, likely SaaS/product
Valuationup to $300 million (potential)
About
Our mission is to provide a highly differentiated minimally-invasive surgical solution designed to customize the visual outcome of the pseudophakic eye. Primary product is the AccuraSee Intraocular Pseudophakic Contact Lens (IOPCL) invented by Kevin Cady, CEO and Founder of OnPoint Vision, Inc.
Product
- Value proposition
- Minimally-invasive surgical solution to customize visual outcomes for pseudophakic eyes and address vision decline from retinal diseases through AccuraSee intraocular lens technology
- Target customers
- ophthalmologists, eye care clinics, surgical centers
- Regulatory
- FDA interaction noted; regulatory pathway not fully specified
Founders
- Kevin Cady — Founder and CEO
Categories
Products
AccuraSee Intraocular Pseudophakic Contact Lens (IOPCL)CadyLensintraocular lens implants
Key features
minimally-invasive surgical solutioncustomizes visual outcome of pseudophakic eyedesigned to fine-tune refractive errorvision recovery for retinal pathology
Technologies
intraocular lensespseudophakic contact lensesophthalmic implants
Target conditions
Residual refractive error after cataract surgeryage-related retinal pathologies (e.g., macular degeneration)visual decline post-cataract surgery
Care settings
clinicophthalmology practiceoperating roomhospital
Certifications
FDA (initial proposal accepted; later pathway discussion)CLIA/HITRUST not specified
Competitors
other intraocular lens/IOPCL devices, refractive lens implants competitors
Investors
WP Global PartnersRefocus Group, Inc.
News
- INTRAOCULAR PSEUDOPHAKIC CONTACT LENS WITH MECHANISM FOR SECURING BY ANTERIOR LEAFLET OF CAPSULAR WALL AND RELATED SYSTEM AND METHOD - Patent Application · 2025-10-16T05:00:00.000Z
- OCULAR DRUG DELIVERY DEVICES SECURELY IMPLANTABLE INTO ANTERIOR SEGMENT OF EYE - Patent Application · 2025-07-03T05:00:00.000Z
- OnPoint AR-AI Receives Award for Granted U.S. Patent Covering Augmented Reality (AR) Display for Spinal Rod Placement Related Applications | OnPoint AR-AI · 2025-01-30T18:28:44.000Z
- Onpoint Ups the HealthTech Ante | Iris Medical Agent AI Platform · 2025-06-25T05:46:00.000Z
- OnPoint to present its Augmented Reality AR-AI Technology Platform at the 2024 Wells Fargo Healthcare Conference · 2024-09-04T01:23:00.000Z
- Onpoint Launches Practice Management as a Service (PMaaS™), Enhances Leadership Team - Onpoint Healthcare Partners Inc. · 2025-10-21T22:37:04.000Z


